GST Council Slashes Tax on Medical Devices, Lifesaving Drugs
The Council has reduced GST on a wide range of medical apparatus and devices — used for medical, surgical, dental, or veterinary purposes as well as for physical or chemical analysis — from 18 percent to five percent.
Industrial talks | 04/09/2025 | By Dineshwori | 164
Shukra Pharmaceuticals has received a Letter of Award (LoA) from HSCC (India) Ltd. for the supply of medicines and diagnostic kits to Afghanistan.
Industrial talks | 01/09/2025 | By Dineshwori
Vivanza Biosciences Appoints Sarang Bharatbhai Pathak as Additional Director
As Additional Director, Sarang Bharatbhai Pathak will oversee Vivanza’s comprehensive portfolio encompassing sales and marketing, sourcing, deal negotiation, stakeholder relations, operational oversight, strategic leadership, and risk management.
Industrial talks | 30/08/2025 | By Dineshwori
Indoco Remedies Signs Sale and Lease Agreement with OPC Asset Solution
Indoco has signed an agreement with OPC Asset Solution for the sale and subsequent leaseback of certain movable properties at its Waluj Facility in Aurangabad and its AnaCipher Clinical Research Organisation (CRO) in Hyderabad, Telangana.
Industrial talks | 30/08/2025 | By Dineshwori
Harbour BioMed Names Yajie Li as Chief Medical Officer
As Chief Medical Officer (CMO), Yajie Li will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.
Industrial talks | 25/08/2025 | By Dineshwori
Parexel Names Jim Anthony Chief Commercial Officer and President, Biotech Division
Parexel, a leading global clinical research organization (CRO), has appointed Jim Anthony as chief commercial officer (CCO) and president of Parexel Biotech, expanding his responsibilities to strengthen the company’s customer focus and accelerate growth.
Industrial talks | 22/08/2025 | By Darshana
Eli Lilly Announces Retirement of Anne White, Begins Search for Next Neuroscience Chief
Eli Lilly has announced that Anne White, Executive Vice President and President, Lilly Neuroscience, will retire from the company on December 31, 2025, after three decades of service.
Industrial talks | 21/08/2025 | By Dineshwori | 273
Telangana has reaffirmed its global leadership in life sciences, with investments surpassing INR 54,000 Crore in the past year alone, and the city is now ranked among the top 7 life sciences clusters globally (only Indian city).
Industrial talks | 21/08/2025 | By Darshana | 100
Viatris Names Andrew Enrietti Chief Administrative and Transformation Officer
Viatris Inc. has appointed Andrew Enrietti as its Chief Administrative and Transformation Officer – a newly created position.
Industrial talks | 20/08/2025 | By Dineshwori | 116
CCI Approves Stake Buy in Micro Life Sciences by Abu Dhabi Investment Authority-Owned Entity
The Competition Commission of India (CCI) has approved the proposed acquisition of a stake in Micro Life Sciences Pvt. Ltd. (Meril) by Platinum Jasmine A 2018 Trust, an investment entity owned and controlled by the Abu Dhabi Investment Authority (ADIA).
Industrial talks | 20/08/2025 | By Dineshwori | 329
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy